Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,350 | 2,398 | 2,406 | 2,213 | 299 |
| Cost of Goods | 1,440 | 1,408 | 1,573 | 1,665 | 75 |
| Gross Profit | 910 | 990 | 833 | 549 | 224 |
| Operating Expenses | 3,324 | 3,486 | 3,352 | 3,556 | 2,593 |
| Operating Income | -1,974 | -2,088 | -1,945 | -2,342 | -2,295 |
| Interest Expense | 22 | 22 | 24 | 25 | 9 |
| Other Income | -3 | 5 | 11 | -3 | 15 |
| Pre-tax Income | -1,998 | -2,105 | -1,958 | -2,371 | -2,289 |
| Income Tax | 3 | 5 | 4 | 2 | 2 |
| Net Income Continuous | -2,001 | -2,110 | -1,962 | -2,373 | -2,291 |
| Net Income | $-2,001 | $-2,110 | $-1,962 | $-2,373 | $-2,291 |
| EPS Basic Total Ops | -0.16 | -0.19 | -0.20 | -0.27 | -0.26 |
| EPS Basic Continuous Ops | -0.16 | -0.19 | -0.20 | -0.26 | -0.26 |
| EPS Diluted Total Ops | -0.16 | -0.19 | -0.20 | -0.27 | -0.26 |
| EPS Diluted Continuous Ops | -0.16 | -0.19 | -0.20 | -0.26 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.19 | -0.21 | -0.26 | -0.26 |
| EBITDA(a) | $-1,823 | $-1,937 | $-1,796 | $-2,194 | $-2,237 |